<DOC>
	<DOCNO>NCT01634347</DOCNO>
	<brief_summary>The treatment involve administer propranolol , medication indicate treat high blood pressure . Propranolol hypothesize reduce strength drug alcohol craving ( integral factor involve relapse ) , specifically memory substance use recall . In study , propranolol placebo administer patient participate drug alcohol rehabilitation facility week three six week . After receive propranolol placebo , strong memory associate substance crave recall ask participant read aloud summary substance use experience . The investigator hypothesize participant receive propranolol report few less intense drug alcohol craving participant receive placebo treatment-as-usual .</brief_summary>
	<brief_title>Memory Reconsolidation Blockade Treating Drug Addiction</brief_title>
	<detailed_description>Trial Objectives : To test feasibility reconsolidation blockade adjunct treatment reduce drug alcohol craving individual diagnose substance dependence substance abuse disorder participate drug rehabilitation program . Study Design Duration : This study 3 6 week , randomize , double-blind trial involve participant DSM-IV-TR diagnosis substance dependence abuse . Consented participant meet enrolment criterion receive dose propranolol ( 1mg/kg ) placebo ninety minute undergo brief memory reactivation procedure twice week three-week period ( week six week period , depend participant availability ) adjunct usual drug rehabilitation treatment . Participants randomize one two treatment arm ( i.e . placebo group + treatment usual , propranolol group + treatment usual ) remain arm duration study . Participants placebo arm offer opportunity continue receive open-label propranolol treatment another 3-6 week follow double-blind phase study . A four-month follow-up assessment also conduct .</detailed_description>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<criteria>Male female subject 18 65 year age Female subject must child bear potential non pregnant establish acceptable method birth control one abstain sex Diagnosis substance dependence substance abuse disorder within 1month period prior screen Currently enrol drug rehabilitation treatment program marijuana , cocaine , heroin , opiates , benzodiazepine , alcohol , amphetamine addiction Individuals consent remain abstinent drug abuse ( except nicotine ) alcohol 24 hour prior enrolment duration study Individuals treat follow medication must stable dos least 1month prior screen visit entire study : anxiolytic , sedative , hypnotic , antidepressant , antipsychotic Individuals take Selective Serotonin Reuptake Inhibitors ( SSRIs ) SerotoninNorepinephrine Reuptake Inhibitors ( SNRIs ) must accept skip morning dose day study visit Individuals shall start take new medication regular basis study Fluency French English Systolic blood pressure &lt; 100 mm Hg Cardiac rhythm 55 beat per minute A medical condition contraindicates administration propranolol Previous adverse reaction , noncompliance , betablocker Current use medication may involve potentially dangerous interaction propranolol . Women pregnant breast feeding Past present bipolar disorder psychosis Individuals current dependence substance besides , cocaine , heroin , opiates , benzodiazepine , amphetamine , marijuana , alcohol Subjects judge significant risk self injurious/suicidal violent/homicidal behavior Participation another drug trial within 30 day prior screen visit study Any condition significantly affect absorption study medication Presence clinical condition might interfere interpretation efficacy safety result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>